company
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_483 · inspection_citation2025-01-06Suzhou Suncadia Biopharmaceuticals Co., Ltd. -- FDA 483: 3 observations (2025-01-06)
Frequently asked questions
- How many FDA warning letters has Suzhou Suncadia Biopharmaceuticals Co., Ltd. received?
- Argus HQ has not recorded an FDA warning letter for Suzhou Suncadia Biopharmaceuticals Co., Ltd. in our current dataset.
- What FDA recalls has Suzhou Suncadia Biopharmaceuticals Co., Ltd. issued?
- Argus HQ has not recorded an FDA recall tied to Suzhou Suncadia Biopharmaceuticals Co., Ltd. in our current dataset.
- Is Suzhou Suncadia Biopharmaceuticals Co., Ltd. FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 0 approval records for Suzhou Suncadia Biopharmaceuticals Co., Ltd.. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.